{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:27:44Z","timestamp":1792801664302,"version":"4.5.0"},"reference-count":259,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2024,8,2]]},"DOI":"10.1080\/14737175.2024.2370346","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T03:46:23Z","timestamp":1719287183000},"page":"743-759","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Current nonstimulant medications for adults with attention-deficit\/hyperactivity disorder"],"prefix":"10.1080","volume":"24","author":[{"given":"Giulio Emilio","family":"Brancati","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Magnesa","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Acierno","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carli","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"De Rosa","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Froli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Gemignani","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ventura","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Perugi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2021.01.022"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30190-0"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyt261"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.11.04009"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2018.11.001"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S1747"},{"key":"e_1_3_4_9_1","volume-title":"Canadian ADHD Practice Guidelines. 4.1 Edition","author":"Canadian ADHD Resource Alliance (CADDRA)","year":"2020","unstructured":"Canadian ADHD Resource Alliance (CADDRA). Canadian ADHD Practice Guidelines. 4.1 Edition. Toronto (ON): Canadian ADHD Resource Alliance; 2020."},{"key":"e_1_3_4_10_1","volume-title":"Attention deficit hyperactivity disorder: diagnosis and management","author":"National Institute for Health and Care Excellence (NICE)","year":"2019","unstructured":"National Institute for Health and Care Excellence (NICE). Attention deficit hyperactivity disorder: diagnosis and management. London: National Institute for Health and Care Excellence; 2019."},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2.4.573"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.7270\/47\/98\/0005-0347\/$05.00\/0"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(02)00346-9"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001763"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301315"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.27"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0060708"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705172"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2004.05.018"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01671-2"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.12.015"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114542453"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.6.4.379"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/appy.12160"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054713510352"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12402-016-0212-7"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054709342203"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.5.693"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-9081-1-16"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2016.08.017"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2023.2168750"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.2165\/11631990-000000000-00000"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054713476549"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318192e4a0"},{"key":"e_1_3_4_35_1","volume-title":"European College of Neuropsychopharmacology 19th ECNP Congress","author":"Bieck P","year":"2005","unstructured":"Bieck P, Leibowitz M, Ereshefsky L, et al. Use of a biomarker of norepinephrine transporter (NET) inhibition to assess atomoxetine effects during clinically recommended dosing. In: European College of Neuropsychopharmacology 19th ECNP Congress; Paris, France; 2005."},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116636105"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e31820c00eb"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/appy.12119"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0304"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054708316250"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000239797.21826.70"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104175"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1291319"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1758-5872.2012.00204.x"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31827d8a23"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054707308490"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0346-3"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3182560315"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.03.003"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.10.014"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054706292122"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054708322986"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2012.08.001"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2013.06.001"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.12272"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.11.014"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116632377"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2023.2263645"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2017.08.010"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2014.12.002"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.04.040"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12402-011-0054-2"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2015.0137"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011398657"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054716661235"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12253"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12442"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12595"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2014.09.2814"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0323-x"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12533"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2015.09.005"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115602489"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S150261"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000138"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.4321\/S0213-61632013000300004"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12402-017-0227-8"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054716664411"},{"issue":"1","key":"e_1_3_4_79_1","article-title":"Maintenance of effect in attention deficit hyperactivity disorder: what do placebo-controlled randomized withdrawal studies of atomoxetine and stimulants tell us?","volume":"25","author":"Peksel H","year":"2015","unstructured":"Peksel H, Upadhyaya H, Adams DH, et al. Maintenance of effect in attention deficit hyperactivity disorder: what do placebo-controlled randomized withdrawal studies of atomoxetine and stimulants tell us? Bull Clin Psychopharmacol [Internet]. 2015;25(1). Available from: www.psikofarmakoloji.org","journal-title":"Bull Clin Psychopharmacol [Internet]"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S97724"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12402-016-0194-5"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2013.800524"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S98498"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2010.02159.x"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114560183"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2015.05.006"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001039"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014541791"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2015.1083394"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.530"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0349-0"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0410-7"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15081789"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200326100-00006"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005276737"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30269-4"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.43597"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2023.4294"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1208456"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.05.044"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200721060-00003"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2014.0005"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2016.06.005"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.5765\/jkacap.220040"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.941804"},{"key":"e_1_3_4_106_1","article-title":"Comorbidities in youth with bipolar disorder: clinical features and pharmacological management","volume":"20","author":"Sesso G","year":"2022","unstructured":"Sesso G, Brancati GE, Masi G. Comorbidities in youth with bipolar disorder: clinical features and pharmacological management. Curr Neuropharmacol [Internet]. 2022 Jul 6;20. Available from: https:\/\/www.eurekaselect.com\/206662\/article","journal-title":"Curr Neuropharmacol [Internet]"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7176.198954"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1079620"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2008.08.006"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181e29174"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40211-014-0103-0"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-226020"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S115707"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12402-011-0063-1"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.20549"},{"issue":"3","key":"e_1_3_4_116_1","first-page":"5","article-title":"Patient characteristics and treatment response to atomoxetine in adults with ADHD versus ADHD comorbid with social anxiety disorder","volume":"1","author":"Adler L","year":"2010","unstructured":"Adler L, Rubin R, Qiao M, et al. Patient characteristics and treatment response to atomoxetine in adults with ADHD versus ADHD comorbid with social anxiety disorder. J ADHD Relat Disord. 2010;1(3):5\u201315.","journal-title":"J ADHD Relat Disord"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2022.20.1.143"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0312"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.23248"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2010.537224"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.02.009"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.628648"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1080\/15504260802628767"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2010.00076.x"},{"issue":"6","key":"e_1_3_4_125_1","first-page":"635","article-title":"Childhood behavior and learning problems treated with imipramine","volume":"1","author":"Rapoport J","year":"1965","unstructured":"Rapoport J. Childhood behavior and learning problems treated with imipramine. Int J Neuropsychiatry. 1965 Dec;1(6):635\u2013642.","journal-title":"Int J Neuropsychiatry"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(65)72256-1"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(73)71321-9"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770120057005"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.133.9.1013"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780290083009"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.5.547"},{"issue":"7","key":"e_1_3_4_132_1","first-page":"76","article-title":"Pharmacotherapy of attention-deficit\/hyperactivity disorder in adults","volume":"59","author":"Wender PH","year":"1998","unstructured":"Wender PH. Pharmacotherapy of attention-deficit\/hyperactivity disorder in adults. J Clin Psychiatry. 1998;59(Suppl 7):76\u201379.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.1992.2.267"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199501000-00010"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.9.1147"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1089\/10445460050167304"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(83)90006-9"},{"issue":"2","key":"e_1_3_4_138_1","first-page":"222","article-title":"Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, \u201cminimal brain dysfunction,\u201d \u201chyperactivity\u201d) in adults","volume":"21","author":"Wender PH","year":"1985","unstructured":"Wender PH, Wood DR, Reimherr FW. Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, \u201cminimal brain dysfunction,\u201d \u201chyperactivity\u201d) in adults. Psychopharmacol Bull. 1985;21(2):222\u2013231.","journal-title":"Psychopharmacol Bull"},{"issue":"3","key":"e_1_3_4_139_1","first-page":"327","article-title":"Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety","volume":"32","author":"Ernst M","year":"1996","unstructured":"Ernst M, Liebenauer LL, Jons PH, et al. Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety. Psychopharmacol Bull. 1996;32(3):327\u2013334.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1985.01790330042005"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246258"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199612000-00018"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009504.pub2"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.8.1018"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.01.027"},{"issue":"9","key":"e_1_3_4_146_1","first-page":"675","article-title":"Bupropion in adults with attention-deficit\/hyperactivity disorder: a randomized, double-blind study","volume":"52","author":"Akhondzadeh S","year":"2014","unstructured":"Akhondzadeh S, Hamedi M, Mohammadi M, et al. Bupropion in adults with attention-deficit\/hyperactivity disorder: a randomized, double-blind study. Acta Med Iran [Internet]. 2014 [cited 2024 Feb 6];52(9):675\u2013680. Available from: https:\/\/acta.tums.ac.ir\/index.php\/acta\/article\/view\/4661","journal-title":"Acta Med Iran [Internet]"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.2.282"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s12160146"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01664-5"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.06.012"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v21n02_01"},{"key":"e_1_3_4_152_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852921000328"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.23m14934"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S256586"},{"key":"e_1_3_4_155_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-022-00938-w"},{"key":"e_1_3_4_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114922"},{"key":"e_1_3_4_157_1","volume-title":"American Society of Clinical Psychopharmacology annual meeting","author":"Cutler A","year":"2023","unstructured":"Cutler A, Childress A, Adler L, et al. Qelbree: Final results of the long-term, phase 3, open-label extension trial in adults with ADHD. In: American Society of Clinical Psychopharmacology annual meeting; 2023 May 30\u2013Jun 2; Miami, Florida; 2023."},{"key":"e_1_3_4_158_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-023-01023-6"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2023.2265068"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.1996.6.165"},{"key":"e_1_3_4_161_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0412"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.12.017"},{"issue":"4","key":"e_1_3_4_163_1","first-page":"779","article-title":"An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder","volume":"31","author":"Hedges D","year":"1995","unstructured":"Hedges D, Reimherr FW, Rogers A, et al. An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. Psychopharmacol Bull. 1995;31(4):779\u2013783.","journal-title":"Psychopharmacol Bull"},{"issue":"4","key":"e_1_3_4_164_1","first-page":"785","article-title":"Open-label trial of venlafaxine in adults with attention deficit disorder","volume":"31","author":"Adler LA","year":"1995","unstructured":"Adler LA, Resnick S, Kunz M, et al. Open-label trial of venlafaxine in adults with attention deficit disorder. Psychopharmacol Bull. 1995;31(4):785\u2013788.","journal-title":"Psychopharmacol Bull"},{"issue":"5","key":"e_1_3_4_165_1","first-page":"184","article-title":"Venlafaxine in adults with attention-deficit\/hyperactivity disorder: an open clinical trial","volume":"57","author":"Findling RL","year":"1996","unstructured":"Findling RL, Schwartz MA, Flannery DJ, et al. Venlafaxine in adults with attention-deficit\/hyperactivity disorder: an open clinical trial. J Clin Psychiatry. 1996 May;57(5):184\u2013189.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_4_166_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200102000-00025"},{"key":"e_1_3_4_167_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1274"},{"issue":"3","key":"e_1_3_4_168_1","first-page":"231","article-title":"A comparison of the effects of reboxetine and placebo on reaction time in adults with Attention Deficit-Hyperactivity Disorder (ADHD)","volume":"19","author":"Hashemian F","year":"2011","unstructured":"Hashemian F, Mohammadian S, Riahi F, et al. A comparison of the effects of reboxetine and placebo on reaction time in adults with Attention Deficit-Hyperactivity Disorder (ADHD). Daru. 2011;19(3):231\u2013235.","journal-title":"Daru"},{"key":"e_1_3_4_169_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1158"},{"key":"e_1_3_4_170_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054712443157"},{"key":"e_1_3_4_171_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198905000-00008"},{"key":"e_1_3_4_172_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.124"},{"key":"e_1_3_4_173_1","doi-asserted-by":"publisher","DOI":"10.1159\/000076721"},{"key":"e_1_3_4_174_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119832538"},{"key":"e_1_3_4_175_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198610000-00009"},{"key":"e_1_3_4_176_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199111000-00009"},{"key":"e_1_3_4_177_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-006-0044-9"},{"key":"e_1_3_4_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2020.107327"},{"key":"e_1_3_4_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.09.020"},{"key":"e_1_3_4_180_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2022.0038"},{"key":"e_1_3_4_181_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19m12979"},{"key":"e_1_3_4_182_1","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12152"},{"key":"e_1_3_4_183_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02867-8"},{"key":"e_1_3_4_184_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200104000-00015"},{"key":"e_1_3_4_185_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001387"},{"key":"e_1_3_4_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(02)00859-0"},{"key":"e_1_3_4_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2006.05.010"},{"key":"e_1_3_4_188_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199806)29:2<142:AID-SYN5>3.0.CO;2-7"},{"key":"e_1_3_4_189_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bandc.2006.11.002"},{"key":"e_1_3_4_190_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.07.034"},{"key":"e_1_3_4_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(97)00092-4"},{"key":"e_1_3_4_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2009.03.043"},{"key":"e_1_3_4_193_1","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.20789"},{"key":"e_1_3_4_194_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200609000-00007"},{"key":"e_1_3_4_195_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2011.623716"},{"key":"e_1_3_4_196_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2687"},{"key":"e_1_3_4_197_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054714538656"},{"key":"e_1_3_4_198_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000499"},{"key":"e_1_3_4_199_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00427682"},{"key":"e_1_3_4_200_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02247426"},{"key":"e_1_3_4_201_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00427447"},{"key":"e_1_3_4_202_1","doi-asserted-by":"publisher","DOI":"10.1037\/0735-7044.101.4.457"},{"key":"e_1_3_4_203_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2006.09.015"},{"key":"e_1_3_4_204_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622970209150616"},{"key":"e_1_3_4_205_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.9.1.83"},{"issue":"1","key":"e_1_3_4_206_1","first-page":"67","article-title":"Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD)","volume":"32","author":"Conners CK","year":"1996","unstructured":"Conners CK, Levin ED, Sparrow E, et al. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol Bull. 1996;32(1):67\u201373.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_4_207_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199402000-00006"},{"key":"e_1_3_4_208_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.12.1931"},{"key":"e_1_3_4_209_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.194"},{"key":"e_1_3_4_210_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000204139.20417.8a"},{"key":"e_1_3_4_211_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1026"},{"key":"e_1_3_4_212_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2022.08.013"},{"key":"e_1_3_4_213_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463200301600304"},{"key":"e_1_3_4_214_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1987.tb04111.x"},{"key":"e_1_3_4_215_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1993.tb05579.x"},{"key":"e_1_3_4_216_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12m07767"},{"key":"e_1_3_4_217_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2013.07.2689"},{"key":"e_1_3_4_218_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2014.09.2795"},{"key":"e_1_3_4_219_1","unstructured":"Available from: https:\/\/www.genengnews.com\/news\/alcobra-adhd-candidate-mdx-fails-phase-iii-trial\/"},{"key":"e_1_3_4_220_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199203000-00013"},{"key":"e_1_3_4_221_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.14.3.289"},{"key":"e_1_3_4_222_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567205013666160415154701"},{"key":"e_1_3_4_223_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12826"},{"key":"e_1_3_4_224_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1311-8"},{"key":"e_1_3_4_225_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104975"},{"key":"e_1_3_4_226_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199603000-00017"},{"key":"e_1_3_4_227_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.13.1.72"},{"key":"e_1_3_4_228_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.03.035"},{"key":"e_1_3_4_229_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113493365"},{"key":"e_1_3_4_230_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.1.58"},{"key":"e_1_3_4_231_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09020233"},{"key":"e_1_3_4_232_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2019.12.009"},{"key":"e_1_3_4_233_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2014.05.008"},{"key":"e_1_3_4_234_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054720909084"},{"key":"e_1_3_4_235_1","doi-asserted-by":"publisher","DOI":"10.1097\/chi.0b013e3180323354"},{"key":"e_1_3_4_236_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2018.0068"},{"key":"e_1_3_4_237_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.0012"},{"key":"e_1_3_4_238_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.12.010"},{"key":"e_1_3_4_239_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharma.2013.12.009"},{"key":"e_1_3_4_240_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13346"},{"key":"e_1_3_4_241_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2011.0081"},{"key":"e_1_3_4_242_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-013-0355-6"},{"issue":"6","key":"e_1_3_4_243_1","first-page":"18","article-title":"The dopamine dilemma: using stimulants and antipsychotics concurrently","volume":"7","author":"Yanofski J","year":"2010","unstructured":"Yanofski J. The dopamine dilemma: using stimulants and antipsychotics concurrently. Psychiatry (Edgmont). 2010 Jun;7(6):18\u201323.","journal-title":"Psychiatry (Edgmont)"},{"key":"e_1_3_4_244_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001592"},{"key":"e_1_3_4_245_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2011.01.006"},{"key":"e_1_3_4_246_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093096"},{"key":"e_1_3_4_247_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.11.1652"},{"key":"e_1_3_4_248_1","doi-asserted-by":"publisher","DOI":"10.1177\/10870547211050949"},{"key":"e_1_3_4_249_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156614"},{"key":"e_1_3_4_250_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054716685842"},{"key":"e_1_3_4_251_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2013.841251"},{"key":"e_1_3_4_252_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2022.11.029"},{"key":"e_1_3_4_253_1","doi-asserted-by":"publisher","DOI":"10.1159\/000495307"},{"key":"e_1_3_4_254_1","doi-asserted-by":"publisher","DOI":"10.1159\/000521370"},{"key":"e_1_3_4_255_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.05.005"},{"key":"e_1_3_4_256_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbw003"},{"key":"e_1_3_4_257_1","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990620"},{"key":"e_1_3_4_258_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30074-2"},{"key":"e_1_3_4_259_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e31820c23fa"},{"key":"e_1_3_4_260_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1381"},{"key":"e_1_3_4_261_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.12.002"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2024.2370346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T06:31:11Z","timestamp":1729060271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2024.2370346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":259,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,2]]}},"alternative-id":["10.1080\/14737175.2024.2370346"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2024.2370346","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}